Fenestrated endovascular aneurysm repair (FEVAR) is an alternative to open repair of complex aortic aneurysms. Despite promising short-term results, the technical complexities of this procedure remain a considerable challenge. The risk of technical failure with loss of visceral or renal arteries is ubiquitous even in the most experienced hands, and thus many patients with unfavorable anatomy are frequently denied FEVAR. We have adopted a new technique for FEVAR that involves retrograde brachial artery access and stepwise deployment of the endograft during target vessel catheterization, overcoming many anatomic limitations encountered from a transfemoral approach. This technique, termed sequential catheterization amid progressive endograft deployment, has become our preferred approach for FEVAR and is described in this article. Of note, currently available Food and Drug Administration-approved fenestrated endografts may not be amenable to sequential catheterization amid progressive endograft deployment as this technique requires preloaded wires incorporated into the endografts. (J Vasc Surg 2017;66:311-5.) Fenestrated and branched endovascular aneurysm repair (EVAR) has emerged as an alternative to open surgical repair of juxtarenal, paravisceral, or thoracoabdominal aortic aneurysms in high-risk patients.
Fenestrated and branched endovascular aneurysm repair (EVAR) has emerged as an alternative to open surgical repair of juxtarenal, paravisceral, or thoracoabdominal aortic aneurysms in high-risk patients. [1] [2] [3] [4] [5] The complexities of this procedure carry the risk of technical failure with target vessel loss, and thus patients with unfavorable anatomy are frequently denied fenestrated EVAR (FEVAR). To simplify technical considerations, we have employed a method involving retrograde brachial artery access and partial endograft release to perform target vessel cannulation. This technique, which we have termed sequential catheterization amid progressive endograft deployment (SCAPED), is described herein.
TECHNIQUE
Device details. All cases were performed using fenestrated custom-made devices based on the Zenith endograft platform (Cook Medical, Bloomington, Ind). All devices with an uncovered proximal stent were designed and manufactured with a reinforced access scallop for preloaded wires and catheters that were brought through two fenestrations for access from above using upper extremity access (Fig 1, A) . Because a reinforced double wide or access scallop is used to access the device sequentially, access through an uncovered proximal bare stent in the top cap would be extremely unlikely. The reinforced nature of the scallop allows a smooth transition of the catheters and sheaths and prevents their upward displacement. Alternatively, the preloaded catheters and wires were brought through a proximal trifold configuration similar to the Zenith TX2 TAA Endovascular Graft (Cook Medical ; Fig 1, B) . Every device was designed to match each patient's specific visceral aortic anatomy to include a variety of endograft configurations, such as bilateral renal artery fenestrations with superior mesenteric artery scallop, bilateral renal artery and superior mesenteric artery fenestrations with celiac artery scallop, or four-vessel fenestrations. Endograft configuration was determined by the location of 2 cm of healthy aorta serving as the proximal landing zone. All endografts featured posteriorly positioned constraining sutures, which effectively reduced the graft diameter by approximately 30%. The SCAPED technique was used for patients undergoing FEVAR with investigational devices. These patients were enrolled in a physician-sponsored investigational device exemption study and signed an Institutional Review Board-approved informed consent form to participate in research (ClinicalTrials.gov NCT02266719).
SCAPED technique. Under general anesthesia, unilateral proximal brachial artery exposure and bilateral percutaneous femoral access are completed. Intravascular ultrasound (Volcano, San Diego, Calif) is used to locate the visceral and renal artery orifices, and each is fluoroscopically marked using bone landmarks. The fenestrated device is delivered transfemorally to the abdominal aorta, and a 12F 45-cm Ansel sheath is advanced into the descending thoracic aorta through high brachial artery access. The left or right side may be used for brachial access, depending on the preference of the interventionists. Preoperative imaging of the aortic arch may aid in this decision as one side may be more suitable, depending on the location and anatomy of the great vessels. The endograft is then partially deployed at the appropriate level based on the previously obtained intravascular ultrasound images, exposing the most proximal fenestrations only (Fig 1, A) . Alternatively, precannulation with catheters or wires may be used to mark the position of the target vessels and to aid with the alignment of the fenestrations. The distal graft remains sheathed, allowing vertical or rotational repositioning of the endograft as needed during vessel cannulation (Fig 2, A) . The preloaded wires are removed and replaced by extra support 0.014-inch 300-cm wires, which are subsequently snared and brought out through the brachial sheath (Fig 2, B) . A 7F 70-, 90-, or 110-cm sheath is then advanced through the 12F brachial sheath and advanced over one of the 0.014-inch wires through the access scallop or the trifold proximal end configuration into the inside of the fenestrated endograft (Fig 2, C and D) . Through this 7F sheath and parallel to the 0.014-inch wire, a 0.035-inch wire and catheter combination is placed within the partially deployed endograft, and selective catheterization of the exposed fenestration and target vessel is completed (Fig 2, E and F) ; 100-or 125-cm-long catheters are usually required. Digital subtraction angiography confirms appropriate catheterization, and the cannulation is secured with a heavy-duty wire (Rosen or TAD II). The endograft is then segmentally deployed to expose each consecutive fenestration individually, and using the same technique, sequential catheterization is performed in a proximal to distal orientation. The 7F sheath is completely removed and readvanced over the 0.014-inch wire each time a separate fenestration is cannulated. The 12F brachial sheath is accessed separately for each fenestration. Once all target arteries are secured, the graft is fully deployed and the constraining wire released (Fig 2, G) . The preloaded 0.014-inch wires are also removed.
With the endograft deployed, branches to the target vessels are created using iCAST stents (Atrium Medical, Hudson, NH). A 7F sheath is advanced through the 12F brachial sheath to support stent delivery to the visceral or renal artery origin. Branch stent placement is accomplished in a reversed order starting with the most distal branch and working proximally using covered stents with long catheters (usually longer than 120 cm). Once it is positioned and deployed, the proximal stent is flared within the aortic stent graft with a larger angioplasty balloon. Contrast angiography confirms stent apposition to both the fenestration and target vessel wall. If the fenestrated component has an access scallop, it is preferable to maintain the uncovered proximal stent constrained and to release only the top cap once the target vessels have been stented to avoid trapping the wires with the barbs of the bare stent. Care should be taken when recovering the top cap to avoid crushing and damage of the stents. Maintaining wire access and repeated balloon inflation and flaring may be necessary. The sequential catheterization amid progressive endograft deployment (SCAPED) technique. A, Partial deployment of the proximal endograft; the device is maintained constrained within the sheath just below the renal fenestrations, which allows orientation of the device as required. B, Wires are advanced through the precatheterized renal fenestrations and snared from above. C and D, A 7F sheath is advanced into the endograft and then into the fenestration. E and F, Catheterization of the renal arteries is performed, maintaining the endograft partially constrained, using brachial access. G, The superior mesenteric artery can be cannulated using femoral access, as in this case, or from above using one of the preloaded wires.
The use of the SCAPED technique does not preclude the use of the femoral approach in select cases in which upward orientation of the vessel favors its use over brachial access. Of note, securing the target vessels using the SCAPED technique may indeed facilitate catheterization by the femoral approach as the vessel is not only already "marked" by a wire but aligned with the fenestration. The procedure is completed by implanting a bifurcated endograft with iliac extensions, if required, below the most distal renal artery. A final aortogram with iliofemoral runoff is completed to ensure exclusion of the aneurysm and perfusion of all fenestrated vessels. In select cases, lower extremity and pelvic perfusion can be restored by implanting the bifurcated device and iliac legs before stenting and flaring of the target vessels, which allows closure of the femoral access sites early on in a similar fashion as with the use of branched devices for the endovascular repair of thoracoabdominal aortic aneurysms. Such an approach may be desirable in cases at risk of spinal cord ischemia or severe peripheral arterial disease, although it is feasible only if a trifold proximal end configuration of the fenestrated device is used.
DISCUSSION
A sequential deployment technique of the fenestrated device with progressive caudal catheterization of the fenestrations using brachial access is described. This technique may improve target vessel access and technical success, particularly in more complex cases. Although an exclusive transfemoral approach is used preferentially in most centers performing complex endovascular aortic aneurysm repair with fenestrated endografts, several limitations preclude its universal use. The majority of cases requiring solely bilateral renal artery fenestrations can, however, be successfully completed with femoral access alone. Thus, this approach has become the basis for the design and development of commercially available customized and "off-the-shelf" endografts.
Performing three-or four-vessel FEVAR using the transfemoral approach alone can present significant technical challenges. Importantly, the endograft must be fully exposed to release the distal end of the graft, through which fenestrations can be catheterized and branches fashioned. In so doing, control of the endograft may be significantly reduced and without the option to make positional adjustments to fenestration orientation. Misalignment of fenestrations at this juncture may be unrecoverable with target vessel loss. Furthermore, anatomic considerations such as target artery angle of incidence to the aorta, target artery stenosis, aortic thrombus, and aortic angulation or tortuosity may impede catheterization and branch stent placement, thus significantly increasing the risk of end-organ embolization or technical failure. Many patients with these anatomic characteristics may not be offered FEVAR and be instead subjected to the morbidity and mortality of open repair or succumb to the natural history of their aneurysm.
The SCAPED technique offers several important advantages to accommodate these challenges, even in the most unfavorable of complex anatomic variations. Selective catheterization of target vessels from a brachial approach capitalizes on the caudally directed angulation of the celiac and mesenteric arteries, thus easing cannulation and stent delivery through the fenestration into the target vessel. This same task can be considerably more difficult from a transfemoral approach as the branching angle with the aorta becomes increasingly acute. In addition, renal artery angulation may be favorable to cannulation from a cranial orientation, 6 making this an ideal method for three-and four-vessel FEVAR.
In combination with a brachial approach, the SCAPED technique employs a stepwise, partial deployment of the constrained endograft to sequentially and individually expose each fenestration in a tightly controlled manner. The device can be advanced, retracted, and rotated while only partially deployed to ensure precise alignment of the fenestrations with the target arteries. Furthermore, with each successful catheterization, the device begins to self-align with the visceral aorta, making the subsequent fenestrations orient correctly. The constraining sutures dramatically decrease the diameter of the endograft during progressive deployment, allowing increased intraluminal working room to facilitate selective catheterization. In cases of significant paravisceral aortic angulation, the device may lie against one side or the other of the aortic wall, blocking access to the target vessels, unless perfect alignment is obtained. In this situation, the SCAPED technique may prevent such device apposition, maintaining the fenestrations in a funnel-like configuration as the device is constrained immediately below within its introducer sheath (Fig 2) . In addition, each of these technical facets reduces disruption of mural thrombus and aortic plaque while ultimately improving the probability of technical success.
Brachial approach for FEVAR has been demonstrated to be safe and effective. 7 Contrary to chimney EVAR, which has been associated with a higher incidence of stroke likely associated with the use of separate sheaths that are advanced and withdrawn across the aortic arch and great vessels during the procedure, [8] [9] [10] [11] [12] the placement of a 12F sheath across the arch avoids such a manipulation as all catheter, wire, and sheath exchanges are performed within the sheath. The SCAPED technique requires precannulated or prewired premanufactured fenestrated custom-made devices, which at the present time are not approved for commercial use in the United States. Such devices are available in many parts of the world or through physician-sponsored investigational device exemptions. Of note, the current Zenith fenestrated abdominal aortic aneurysm endovascular graft (ZFEN device) available in the United States cannot be designed with preloaded catheters and wires and therefore is not suitable for the SCAPED technique. As described before, to avoid difficulty in accessing the proximal end of the endograft around the bare suprarenal stent, the device needs to be planned and ordered with preloaded indwelling wires and catheters. These wires are positioned to enter the endograft through the fenestrations and to exit through the proximal scallop of the graft just below the top cap. Once the wires are snared from brachial access, the SCAPED technique can proceed with preloaded access to the fenestrations as the endograft is deployed. Catheters and wires can easily be removed whether the endograft is built with a proximal bare stent or without it. Some difficulty may be encountered when the trifold configuration is used with preloaded catheters. In such cases, it is preferable to release the entire device before attempting removal of the catheters. Alternatively, the fenestrations and branches are just prewired.
CONCLUSIONS
Sequential catheterization of the target vessels through the fenestrations amid progressive endograft deployment may facilitate fenestrated and branched EVAR, particularly in cases of challenging anatomy. Fenestrated and branched endografting remains a highly complex and technically demanding procedure, and standard techniques must continue to evolve to enhance procedural success. Although currently available Food and Drug Administration-approved fenestrated endografts may not be amenable to SCAPED, this technique will likely become more applicable when preloaded wires can be incorporated into manufactured endografts.
INVITED COMMENTARY Andres Schanzer, MD, Worcester, Mass
The successful use of fenestrated endografts for the treatment of complex aortic aneurysms was first published nearly 2 decades ago, in 1999.
1,2 Now, we are in the midst of a rapid evolution of technical advances in endovascular catheter-based treatments for aortic aneurysms. Endografts designed with scallops, fenestrations, and branches allow for stent grafts to be placed across visceral arteries and great arteries of the arch, while preserving flow to the critical end organs supplied by these arteries. New fabrics and stent materials have allowed for these devices to be packaged and delivered through smaller and smaller sheaths. Preloaded wires and catheters, integrated into the actual endovascular graft delivery system, help streamline these complex procedures.
Despite these advances, we remain far from achieving consensus on how best to treat patients with fenestrated and branched endografts. Access to this diverse array of devices remains highly restricted, and substantial resources are required to successfully execute these repairs and care for these complex patients. Very few centers have a large volume of experience with fenestrated
